Jennifer Kayden Lee
Known title: EVP, Head of North AmericaCIK: 0001801372
Associated companies
Transaction History
| RYTM | ▲ Buy | Option Exercise | 35,000 | $850K | 8/13/2026 | View on chart |
| RYTM | ▼ Sell | Open Market | 75,834 | $8.9M | 8/13/2026 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 21,601 | $147K | 8/13/2026 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 22,612 | — | 2/1/2026 | View on chart |
| RYTM | ▼ Sell | Tax Withholding | 9,237 | $1.0M | 2/1/2026 | View on chart |
| RYTM | ▼ Sell | Open Market | 2,035 | $116K | 2/19/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 5,500 | — | 2/16/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,205 | $70K | 2/13/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,205 | $68K | 2/12/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 10 | $564 | 2/12/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 600 | $34K | 2/12/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 4 | $230 | 2/11/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,023 | $59K | 2/11/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,031 | — | 2/11/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 2,295 | $136K | 2/10/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,894 | $111K | 2/10/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 4,189 | $28K | 2/9/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,437 | — | 2/9/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,733 | $104K | 2/5/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,133 | $69K | 2/5/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 200 | $12K | 2/5/2025 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,447 | $86K | 2/4/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 4,513 | — | 2/1/2025 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 20,622 | $140K | 11/11/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 28,717 | $698K | 11/11/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 11,642 | $357K | 11/11/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 38,051 | $2.5M | 11/11/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 17,540 | $1.2M | 11/11/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 11,070 | $748K | 11/11/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 200 | $14K | 11/11/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 9,066 | $357K | 3/20/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 9,169 | $350K | 3/20/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 15,515 | $608K | 3/19/2024 | View on chart |
| RYTM | ▲ Buy | Grant | 33,750 | $0 | 2/16/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 615 | $31K | 2/13/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,023 | $53K | 2/12/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,031 | — | 2/11/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,438 | — | 2/9/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 4,513 | — | 2/1/2024 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,492 | $67K | 2/1/2024 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 12,030 | $82K | 11/14/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 13,677 | $438K | 11/14/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,438 | $23K | 11/9/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,719 | $48K | 11/9/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,719 | $47K | 11/9/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 5,712 | $39K | 11/8/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 3,479 | $100K | 11/8/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 2,233 | $65K | 11/8/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 80 | $544 | 11/3/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 80 | $2K | 11/3/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 4,519 | $31K | 9/5/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 6,166 | $173K | 9/5/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 1,718 | $12K | 8/9/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,718 | $42K | 8/9/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 8,591 | $58K | 8/7/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 11,223 | $271K | 8/7/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 635 | $17K | 2/14/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,031 | — | 2/11/2023 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 3,438 | — | 2/9/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 1,192 | $33K | 2/9/2023 | View on chart |
| RYTM | ▼ Sell | Open Market | 722 | $4K | 2/15/2022 | View on chart |
| RYTM | ▲ Buy | Option Exercise | 2,032 | — | 2/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
RYTM: RBC raises price target to $159, maintains Outperform
RBC Capital kept its Outperform rating on Rhythm Pharmaceuticals and lifted its price target to $159. The new target sits well above the stock’s 52‑week high of $122.20 and higher than the consensus analyst target of $138.59. A recent Benzinga piece also highlighted the stock’s five‑year total return, underscoring its past performance. These developments may influence market perception of the company’s growth prospects.
RYTM: RBC raises price target to $159, maintains Outperform. RBC Capital kept its Outperform rating on Rhythm Pharmaceuticals and lifted its price target to $159. The new target sits well above the stock’s 52‑week high of $122.20 and higher than the consensus analyst target of $138.59. A recent Benzinga piece also highlighted the stock’s five‑year total return, underscoring its past performance. These developments may influence market perception of the company’s growth prospects.